CSIMarket
 



Pacira Biosciences inc   (PCRX)
Other Ticker:  
 
 



 

What are Pacira Biosciences Inc's Business Segments?



Pacira Biosciences Inc. is a pharmaceutical company that specializes in developing and commercializing innovative products for pain management and postsurgical care. The company's segments, products, and services include:

Segments:
1. EXPAREL: This segment includes the company's flagship product, EXPAREL, which is a non-opioid, long-acting local anesthetic that provides post-surgical pain relief. EXPAREL is used to manage pain after surgery, reducing the need for opioid-based medication, and enhancing patient recovery time.

2. IV and Regional Anesthetics: This segment includes other products developed by Pacira Biosciences that provide local anesthesia for a variety of surgical procedures. These products include DEXPATM and DepofoamTM, both of which are long-acting anesthetics.

Products:
1. EXPAREL: This is Pacira Biosciences' primary product that offers a non-opioid, long-acting anesthetic for post-surgical pain management. The product is used in a variety of settings, including hospitals, ambulatory surgery centers, and clinics.

2. DepofoamTM: This product is a combination of a long-acting anesthetic and Depofoam technology, which allows for a sustained release of medication over time. This product is used in a variety of surgical procedures, such as joint replacement surgeries.

3. DEXPATM: This product is a long-acting anesthetic that offers pain relief for up to 72 hours after surgery. This product is used in a variety of surgical procedures, including spine surgery and total knee replacement surgery.

Services:
1. Pain Management Education: Pacira Biosciences offers education and support services to healthcare providers to improve their understanding of pain management and offer better patient care.

2. Clinical Support: The company offers clinical support for patients who are undergoing surgery, providing them with resources and education to improve their recovery and pain management.

Overall, Pacira Biosciences Inc. is a pharmaceutical company that specializes in innovative products and services for pain management and post-surgical care. The company's focus on non-opioid, long-acting anesthetics offers a safe and effective alternative to traditional pain management methods.
   

Pacira Biosciences Inc Tax Rate Companies within the Major Pharmaceutical Preparations Industry


Business Segments Q3
Revenues
(in millions $)
Q3
Income
(in millions $)
(Sep 30 2023)
%
(Profit Margin)
Total 163.93 10.86 6.62 %

Growth rates by Segment Q3
Y/Y Revenue
%
(Sep 30 2023)
Q/Q Revenue
%
Q3
Y/Y Income
%
(Sep 30 2023)
Q/Q Income
%
Total -2.11 % -3.27 % - -57.85 %

To get more information on Pacira Biosciences Inc's Total segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com